The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
9-(2-Methoxyphenyl)-8-oxo-2-(pyridin-4-yl)-8,9-dihydro-7H-purine-6-carboxamide ID: ALA4476132
Cas Number: 869069-51-2
PubChem CID: 7196976
Max Phase: Preclinical
Molecular Formula: C18H14N6O3
Molecular Weight: 362.35
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccccc1-n1c(=O)[nH]c2c(C(N)=O)nc(-c3ccncc3)nc21
Standard InChI: InChI=1S/C18H14N6O3/c1-27-12-5-3-2-4-11(12)24-17-14(22-18(24)26)13(15(19)25)21-16(23-17)10-6-8-20-9-7-10/h2-9H,1H3,(H2,19,25)(H,22,26)
Standard InChI Key: AGLIYPCDJKUNQG-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
6.2195 -5.0131 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.9291 -4.6037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9263 -3.7810 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2177 -3.3758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5114 -4.6042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5126 -3.7831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7321 -3.5282 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2485 -4.1917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7301 -4.8567 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2159 -2.5586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9227 -2.1484 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5073 -2.1515 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.4313 -4.1906 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4795 -5.6288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6786 -5.7964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4248 -6.5724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9710 -7.1815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7742 -7.0093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0242 -6.2335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6340 -5.0104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6339 -5.8287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3414 -6.2361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0495 -5.8264 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.0455 -5.0050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3375 -4.6012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8233 -6.0626 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.3709 -6.6692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 6 1 0
5 6 2 0
6 7 1 0
7 8 1 0
8 9 1 0
9 5 1 0
4 10 1 0
10 11 1 0
10 12 2 0
8 13 2 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
9 14 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
2 20 1 0
19 26 1 0
26 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 362.35Molecular Weight (Monoisotopic): 362.1127AlogP: 1.28#Rotatable Bonds: 4Polar Surface Area: 128.78Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.13CX Basic pKa: 3.24CX LogP: 2.64CX LogD: 2.64Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.56Np Likeness Score: -1.46
References 1. Huang MR, Hsu YL, Lin TC, Cheng TJ, Li LW, Tseng YW, Chou YS, Liu JH, Pan SH, Fang JM, Wong CH.. (2019) Structure-guided development of purine amide, hydroxamate, and amidoxime for the inhibition of non-small cell lung cancer., 181 [PMID:31376567 ] [10.1016/j.ejmech.2019.07.054 ]